baber/WOPTO huggingface dataset:
Patent CA-2918811-A1 (CA)
Inventor: HERRE JURGEN
IPC: H04S3/00
Filed: 2014-07-15
Abstract: A method for mapping a plurality of input channels of an input channel configuration to output channels of an output channel configuration comprises providing a set of rules associated with each input channel of the plurality of input channels, wherein the rules define different mappings between the associated input channel and a set of output channels. For each input channel of the plurality of input channels, a rule associated with the input channel is accessed, determination is made whether the set of output channels defined in the accessed rule is present in the output channel configuration, and the accessed rule is selected if the set of output channels defined in the accessed rule is present in the output channel configuration. The input channels are mapped to the output channels according to the selected rule.
Patent CA-2921166-A1 (CA)
Title: Fluides de transfert de chaleur comprenant du difluoromethane, du pentafluoroethane, du tetrafluoropropene et eventuellement du propane
Inventor: RACHED WISSAM
IPC: C09K5/04
Filed: 2014-09-02
Abstract: L'invention concerne une composition comprenant:- de 11 à 13 % en poids de difluorométhane; - de 58 à 62 % en poids de pentafluoroéthane; - de 18 à 29 % en poids de tétrafluoropropène; et - de 0 à 7 % en poids de propane. Le tétrafluoropropène peut être le 1,3,3,3-tétrafluoropropène ou le 2,3,3,3-tétrafluoropropène. Cette composition peut être utilisée en tant que fluide de transfert de chaleur dans un circuit de compression de vapeur.
Patent CA-2921460-A1 (CA)
Inventor: ELEID RAY
IPC: B66B3/00
Filed: 2016-02-22
Abstract: Systems and methods are provided for monitoring one or more lift devices, such as elevators and escalators. A server obtains code events about a lift device controller via a web services application. The code events are in a first format. The server reformats the code events into a second format using a mapping table, outputting reformatted code events. The server populates a graphical user interface (GUI) with the reformatted code events.  The GUI is accessible by another computing device over the Internet.
Patent CA-2921667-A1 (CA)
Inventor: MARTYNOV PETR NIKIFOROVICH
IPC: B01J8/00
Filed: 2014-04-18
Abstract: ?The invention relates to energy mechanical engineering and can be used in power installations involving a liquid-metal heat carrier. A mass transfer apparatus including a housing and, provided therein, a flow reaction chamber filled with a solid-phase granulated oxidation agent, and an electric heater positioned in the reaction chamber. The housing of the apparatus is equipped with a repository for reserves of the solid-state granulated oxidation agent, said repository being located below the reaction chamber and being made in the form of a cup having a bottom, said cup being connected to the reaction chamber. The technical result consists in extending the operational duration of the mass transfer apparatus.
Patent CA-2922774-A1 (CA)
Title: Retractable, sanitary covering sleeve
Inventor: PRASAD SHIVAJI
IPC: B62D33/00
Filed: 2014-09-10
Abstract: A small container partitioned into two sections - one for housing a pair of retractable cords and the other half for housing a packet containing sanitizing material.  Each of the sections have empty spaces therein and are conjoined together via click-and-lock hinges. The empty spaces between two sections when conjoined, they together house the protective covering sleeve. In operation, a user engages a cart handle by attaching the device thereto, and can detach the two sections from each other easily.  The two sections when separated deploy the protective covering sleeve over the surface of the handle, providing a sanitary surface for the user to grip.
Patent CA-2924097-A1 (CA)
Inventor: RAVIKUMAR SUNDARAM
IPC: A61B17/34
Filed: 2014-09-19
Abstract: A surgical access port assembly including a cannula having a diameter of less than about 3 mm and a tapered hub, capable of attachment to a laparoscopic surgical instrument, connected to the proximal end of the cannula.
Patent CA-2924496-A1 (CA)
Inventor: AMES CHARLEY
IPC: G06F3/048
Filed: 2014-09-16
Abstract: Approaches enable three-dimensional (3D) display and interaction with interfaces (such as a webpage, an application, etc.) when the device is operating in a 3D view mode. For example, interface elements can be highlighted, emphasized, animated, or otherwise altered in appearance, and/or arrangement in the renderings of those interfaces based at least in part on an orientation of the device or a position of a user using the device. Further, the 3D view mode can provide for an animated 3D departure and appearance of elements as the device navigates from a current page to a new page.
Patent CA-2925179-A1 (CA)
Inventor: SINGER NICHOLAS J
IPC: B62D33/02
Filed: 2016-03-24
Abstract: A replacement tailgate for the purpose of elongating the pickup truck may be installed on a truck bed wherein the replacement tailgate can be unfolded in order to elongate a length of the truck bed. The replacement tailgate may have front and rear shells that are used to support objects placed in the truck bed as well as act as the new tailgate when the truck bed length is elongated. Various panels may be unfolded in order to trap objects within the truck bed when the replacement tailgate is unfolded in order to elongate the truck bed length.
Patent CA-2928235-A1 (CA)
Title: Procedes de traitement de dystrophies musculaires
Inventor: NIQUE FRANCOIS
IPC: A61K31/4166
Filed: 2014-10-24
Abstract: L'invention concerne, notamment, le traitement d'une dystrophie musculaire (par exemple, la dystrophie musculaire de Duchenne) au moyen d'une composition, par exemple, une composition comprenant un composé (I) ou un sel pharmaceutiquement acceptable, un promédicament ou son métabolite.
Patent CA-2931884-A1 (CA)
Inventor: LIU SHENG
IPC: H04W16/14
Filed: 2013-11-29
Abstract: Embodiments of the present invention provide a method for reducing a self-interference signal in a communications system, and an apparatus, where the method includes:  sending a sounding signal; receiving an echo signal, where the echo signal includes a near-field reflected signal corresponding to the sounding signal; separating the near-field reflected signal corresponding to the sounding signal from the echo signal; determining a near-field reflection channel parameter according to the near-field reflected signal; determining a reconstructed near-field reflected self-interference signal based on the near-field reflection channel parameter;  and subtracting the reconstructed near-field reflected self-interference signal from a received second communication signal. According to the method and apparatus that are provided by the present invention, a near-field reflection channel parameter used to estimate a near-field reflected self-interference signal can be determined, and near-field reflected self-interference signals in signals received from another apparatus are reduced by using the near-field reflection channel parameter.
Patent CA-2932436-A1 (CA)
Title: Compositions et procedes d'utilisation de systemes crispr-cas dans les maladies dues a une repetition de nucleotides
Inventor: ZHANG FENG
IPC: C12N15/85
Filed: 2014-12-12
Abstract: L'invention concerne la distribution, la conception et l'optimisation de systèmes, de procédés et de compositions pour la manipulation de séquences et/ou d'activités de séquences cibles. L'invention concerne des systèmes de distribution et des tissus ou organes qui sont ciblés en tant que sites de distribution. L'invention concerne également des vecteurs et des systèmes vecteurs, dont certains codent un ou plusieurs éléments d'un complexe SIN CRISPR, ainsi que des procédés pour la conception et l'utilisation de tels vecteurs. L'invention concerne en outre des méthodes d'orientation de la formation du complexe SIN CRISPR dans des cellules eucaryotes en vue de garantir une meilleure spécificité pour la reconnaissance cible et l'évitement de toxicité, et pour éditer ou modifier un site cible d'un locus génomique présentant un intérêt afin de modifier ou d'améliorer le statut d'une maladie ou d'une pathologie.
Patent CA-2932921-A1 (CA)
Inventor: MAYER M LAURENT
IPC: G07F7/08
Filed: 2016-06-13
Abstract: The invention relates to a method for detecting a fraudulent electronic payment terminal comprising a step, implemented by a mobile terminal independently and prior to the transaction phase, for generating an alarm indicating that said electronic payment terminal is fraudulent, said step for generating an alarm being activated: .cndot. when no message coming from the electronic payment terminal is received by the mobile terminal before the expiry of a predetermined timeout period; or .cndot. when a phase of verifying a response, received from said electronic payment terminal to a challenge sent out by said mobile terminal delivers a negative verification result, said step of verification being implemented by said mobile terminal.
Patent CA-2934097-A1 (CA)
Inventor: ZHU NING
IPC: B01J4/00
Filed: 2014-12-17
Abstract: L'invention concerne un procédé de production de polyamides au moyen d'un système de buses de pulvérisation, agencé pour provoquer la collision de jets de pulvérisation et comprenant au moins une première buse de pulvérisation qui forme un premier jet de pulvérisation ayant une première aire de section et un premier axe d'extension, et une deuxième buse de pulvérisation qui forme un deuxième jet de pulvérisation ayant une deuxième aire de section et un deuxième axe d'extension. La première et la deuxième buse de pulvérisation présentent une direction de pulvérisation orientée dans le sens du champ gravitationnel et elles sont disposées l'une par rapport à l'autre de telle façon que les jets de pulvérisation formés entrent en collision, dans la direction de pulvérisation orientée dans le sens du champ gravitationnel, dans une zone de collision. Le procédé est caractérisé en ce que l'angle formé entre le premier et le deuxième jet de pulvérisation va de 5° à 170° et en ce que la première et la deuxième buse de pulvérisation sont disposées de telle façon que, lors de la collision, la première aire de section du premier jet de pulvérisation forme une intersection avec la deuxième aire de section du deuxième jet de pulvérisation.
Patent CA-2935965-A1 (CA)
Title: Solid forms of tenofovir
Inventor: HURLEY PAUL BERNARD
IPC: C07F9/6561
Filed: 2015-01-09
Abstract: The present invention relates to solid forms of tenofovir and methods for preparation, use and isolation of such forms.
Patent CA-2936690-A1 (CA)
Title: Proteines immobilisees et utilisation de celles-ci
Inventor: CASSIMJEE KARIM ENGELMARK
IPC: C12P1/00
Filed: 2015-01-30
Abstract: L'invention concerne un matériau protéique immobilisé comprenant une protéine qui est immobilisée sur un matériau en verre ou un polymère organique par liaison d'un marqueur d'affinité. Le matériau en verre peut être un matériau en verre poreux tel qu'un verre à porosité régulée (hybride). L'invention concerne également l'utilisation d'un matériau enzymatique immobilisé en tant que biocatalyseur hétérogène dans la synthèse chimique. L'invention concerne en outre un procédé d'immobilisation de protéines portant un marqueur d'affinité sur un matériau en verre ou un polymère organique, et un procédé de purification et d'isolement de protéines portant un marqueur d'affinité par l'immobilisation de telles protéines sur un matériau en verre ou un polymère organique.
Patent CA-2938351-A1 (CA)
Inventor: LYSEN HEINRICH
IPC: G01D9/00
Filed: 2015-01-15
Abstract: A measuring device (22) comprises at least one transmitting part (25) which can be attached to measurement objects (30) and which has at least one data memory (31) and at least two first electrical contacts (27) having respective surfaces that form respective sub-areas of a bearing face of the transmitting part (25), at least one data reading part (26) which has at least two second electrical contacts (28) having respective surfaces that form respective sub-areas of a bearing face of the data reading part (26), and at least one magnet (29). The measuring device (22) here is designed to assume an uncoupled state in which the first electrical contacts (27) are at a distance from the second electrical contacts (28), and to assume a coupled state in which the data reading part (26) and the transmitting part (25) are coupled to one another due to an attraction force brought about by the magnet (29), wherein the bearing face of the transmitting part (25) and the bearing face of the data reading part (26) bear against one another and one of the first electrical contacts (27) in each case bears with its surface against the surface of a respective one of the second electrical contacts (28), as a result of which electrically conductive connections exist between respective first contacts (27) and second contacts (28) bearing against one another, which connections make it possible for the data reading part (26) to read data stored in the data memory (31).
Patent CA-2939361-A1 (CA)
Title: Optical electric field sensors having passivated electrodes
Inventor: WILSON GLENN A
IPC: E21B47/09
Filed: 2014-02-28
Abstract: Permanent electromagnetic (EM) monitoring of the regions around and between wells may employ a casing string positioned within a borehole through the subsurface formations of interest. At least two passivated electrodes are mounted on the casing string to sense electric fields in the formation. Though only capacitively coupled to the formation, the passivated electrodes nevertheless provide a potential difference to an electro-optical transducer, which in turn modifies a property of the light passing along an optical fiber attached to the casing string. An interface unit senses the modified property to derive a measure of the electric field between each pair of passivated electrodes. The passivated electrodes have a contact surface that is conductive but for one or more layers of non-reactive (and thus electrically insulating) materials. Illustrative materials include metal oxides, polymers and ceramics, but the layers are preferably kept very thin to maximize the coupling capacitance with the formation.
Patent CA-2940246-A1 (CA)
Title: Page cache write logging at block-based storage
Inventor: WEI DANNY
IPC: G06F12/0866
Filed: 2015-03-10
Abstract: A block-based storage system may implement page cache write logging. Write requests for a data volume maintained at a storage node may be received at a storage node. A page cache for may be updated in accordance with the request. A log record describing the page cache update may be stored in a page cache write log maintained in a persistent storage device. Once the write request is performed in the page cache and recorded in a log record in the page cache write log, the write request may be acknowledged. Upon recovery from a system failure where data in the page cache is lost, log records in the page cache write log may be replayed to restore to the page cache a state of the page cache prior to the system failure.
Patent CA-2940505-A1 (CA)
Title: Hybridoma cell lines (my-c-cc0c2-259-1 a4) and use thereof for producing a monoclonal antibody against the human cardiac myosin binding protein c (c-protein, mybpc3, cmybp-c or my-c)
Inventor: WEBER EKKEHARD
IPC: C07K16/18
Filed: 2015-01-23
Abstract: The aim of the invention is to produce, in vitro, monoclonal antibodies against cardiac epitopes of the human My-C by generating myeloma cell clones, which produce said specific antibodies with epitope specificity. Said monoclonal antibodies should, amongst other things, enable an ELISA (Enzyme-Linked Immuno Sorbent Assay) for the specific, cross-reactivity free quantitative determination of My-C in serum, plasma or full blood, to be formed. Said aim is achieved by generating a hybridome cell clone which produces a monoclonal antibody which recognizes and binds with a cardiac epitope in the My-C and which does not have the cross-reactivity with respect to the myosin binding proteins of the skeletal muscle. Said hybridome cell line can be obtained by fusing myelome cells with spleen cells of a test animal, in particular a mouse, immunized against recombined My-C. The invention also relates to epitope specific antibodies produced by the hybridome cell lines and to the use thereof.
Patent CA-2941551-A1 (CA)
IPC: B44D3/18
Filed: 2016-08-31
Abstract: Disclosed is a Friction Fit Canvas Stretcher Bar Framing System with a combined built in Ball Slot Canvas Fastening System. It is specifically designed for Artists and for those who commercially produce picture frames and ready to hang art that has been done on canvas or a similar type of material. Designed for quick easy manual or automated mechanical mounting.  This unique interlocking friction fit framing and fastening system does not require any tools to assemble and it does not require any special skills or tools to properly stretch and attach canvas or similar type material onto a frame. Uniform, precision cut, interlocking, frame sections consisting of straight and curved sections, each with a protruding male end and a recessed female end connect together by aligning a male end over top of a corresponding sections female end and then pressing down. The male end slides into the female end to form a tight friction fit connection and a perfect 90 degree corner. Frame sections come in various standard stretcher bar lengths, widths, depths and profiles and can easily be assembled to form rectangular, square, round and oval shaped frames in an array of sizes. Canvas is evenly stretched and attached to a frame using a unique built in Ball Slot Fastening System and 2 rubber splines which are reusable and unlike staples, adhesives and clamps they are easy to install and uninstall and they do not cause any damage to the canvas or to the frame. Frame sections can easily be assembled and disassembled and canvas can be attached and detached for compact shipping and for repeated use.
Patent CA-2942697-A1 (CA)
Inventor: MACDONALD LYNN
IPC: C07K16/46
Filed: 2015-03-20
Abstract: Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises (a) a deletion in an immunoglobulin constant region CH1 gene (optionally a deletion in a hinge region) of a heavy chain constant region gene sequence, and (b) replacement of one or all endogenous VH, DH and JH gene segments with at least one unrearranged light chain variable (VL) gene segment and at least one unrearranged light chain joining (JL) gene segment capable of recombining to form a rearranged light chain variable region (VL/JL) nucleotide sequence operably linked to the heavy chain constant region gene sequence comprising a deletion in the CH1 gene and/or insertion of a genetically engineered single rearranged light chain, wherein the mouse is capable of expressing a functional IgM, single domain antigen binding proteins, e.g., VL single domain binding proteins, and a genetically engineered rearranged light chain.
Patent CA-2945122-A1 (CA)
Inventor: KHANFAR ADEL MOHD
IPC: B21C3/00
Filed: 2015-04-02
Abstract: A method for forming a lightweight axle shaft is provided. A first tubular blank is inserted in a die defining an extrusion throat at one end. A tool is inserted into the die having a mandrel with portions of increasing diameter. The tool is moved towards the outlet end of the die to partially extrude the blank through the extrusion throat and form a hollow axle shaft having a variable inner diameter based on the varying diameter of the mandrel. The tool is then removed and a second tubular blank is inserted and placed in engagement with the first blank. The tool, or a different tool, is inserted into the die and again moved towards the outlet end of the die to complete extrusion of the first blank and produce a shaft having diameters at each end that are less than the diameter of an intermediate portion of the shaft.
Patent CA-2946275-A1 (CA)
Inventor: TAKAKURA NOBUYUKI
IPC: A61K47/24
Filed: 2015-04-03
Abstract: La présente invention concerne : un promoteur d'administration de médicament destiné à favoriser l'administration d'un médicament pour le traitement de maladies associées à une angiodysplasie au niveau d'un siège d'infection, le promoteur d'administration de médicament contenant comme principe actif une substance qui active des récepteurs de lysophospholipides; une composition pharmaceutique pour le traitement de maladies associées à une angiodysplasie, la composition pharmaceutique contenant comme principe actif une substance qui active des récepteurs de lysophospholipides; et une méthode de criblage de médicaments pour le traitement de maladies associées à une angiodysplasie, la méthode étant caractérisée en ce qu'elle comprend la sélection d'une substance activant des récepteurs de lysophospholipides, la substance étant exprimée plus particulièrement dans des cellules endothéliales vasculaires au niveau du siège de l'infection.
Patent CA-2948964-A1 (CA)
Inventor: HRUSCHKA STEFFEN
IPC: A23L11/00
Filed: 2015-05-27
Abstract: Disclosed is the obtaining of one or more products of value, at least one of which is sinapic acid and/or a salt of sinapic acid, from a native material mixture.
Patent CA-2952697-A1 (CA)
Inventor: RANGANATHAN VINOD
IPC: C12N9/16
Filed: 2015-06-16
Abstract: The presently disclosed subject matter provides compositions and methods for the expression of CRISPR guide RNAs using the HI promoter. In particular, compositions and methods are provided for the use of the HI promoter to express CRISPR guide RNA (gRNA) with altered specificity of the 5' nucleotide, as well as use of the HI promoter sequence as a bidirectional promoter to express Cas9 nuclease and the gRNA simultaneously. Compositions and methods are also provided for the expression and regulation of gRNA expression in vivo through the use of RNA ribozymes and regulatable aptazymes.
Patent CA-2953073-A1 (CA)
Title: Procedes, dispositifs et systemes pour administration pulmonaire d'agents actifs
Inventor: DAVIDSON PERRY
IPC: A61M15/00
Filed: 2015-06-30
Abstract: La présente invention concerne un système qui comprend un dispositif inhalateur doseur pour la distribution pulmonaire, à un sujet, d'au moins un quantité vaporisée prédéfinie d'au moins un agent pharmacologiquement actif se trouvant dans un matériau végétal, ladite vaporisation étant effectuée par chauffage de manière contrôlée du matériau végétal de façon à vaporiser une quantité vaporisée prédéfinie de l'agent vaporisé. Ledit système comprend en outre un contrôleur en communication avec le dispositif inhalateur, conçu pour commander la quantité vaporisée prédéfinie sur la base de données indiquant au moins un effet pharmacodynamique induit par ledit agent chez le sujet.
Patent CA-2960806-A1 (CA)
Title: System and method for processing biomass
Inventor: SALONEN PETTERI
IPC: C02F11/125
Filed: 2015-09-15
Abstract: System (100) and method for processing biomass. The system comprises a combined heat and power plant (102), an interface (114) for feeding biogas to a traffic fuel production unit, interfaces (114) to a district heating system (106a) and an electrical grid (106b), and a hydrolysis device (108), a digestion device (110), a dryer (116) and a heat recovery unit (112), which are operatively coupled for transferring heat, intermediate products and final products of the process, wherein raw biomass is received into the hydrolysis device (108), biomass processed by the hydrolysis device (108) is fed to the digestion device (110), biogas obtained in the digestion device (110) is fed to the traffic fuel production unit (104), heat is recovered from the hydrolysis device (108), biomass processed by the digestion device (110) is dried by the heat recovered from the hydrolysis device (108), heat is recovered from the dryer (116), heat recovered from the dryer (116) is fed to the hydrolysis device (108) to be used in pre-heating of the received raw biomass, heat recovered from the dryer (116) is fed to the district heating (106a), and production of electricity is fueled by the dried biomass from the dryer (116).